Why pancreatic islets should be regarded and regulated like organs

Area of Science:

• Endocrinology
• Transplantation immunology
• Regenerative medicine

Background:

• Pancreatic islets are complex micro-organs crucial for insulin production.
• Current regulations differentiate between autologous and alloislet transplantation.
• This distinction impacts the feasibility and accessibility of islet transplantation.

Purpose of the Study:

• To argue for a unified regulatory approach for pancreatic islet transplantation.
• To highlight the scientific basis for considering islets as organs.

Main Methods:

• Review of existing scientific literature on islet structure and function.
• Analysis of current regulatory policies for cell and organ transplantation.
• Comparative assessment of autologous and alloislet transplantation protocols.

Main Results:

• Pancreatic islets exhibit organ-level complexity in structure and function.
• Current regulations create illogical disparities in transplant protocols.
• Restrictive policies for alloislet transplantation impede clinical application in the US.

Conclusions:

• Pancreatic islets should be consistently regulated as organs, regardless of source (autologous or allogeneic).
• Revising regulations is crucial to facilitate alloislet transplantation and leverage advancements in the field.
• Addressing regulatory barriers is essential for the future of diabetes treatment through islet transplantation.